NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2026
Back to search
Official data from USPTO
FETAL RESERVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FETAL RESERVE
ST13
US500000098851218Class
1
Filing
98851218
Registration
8207961
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/07/2026
Trademark type
Word
Nice classes
1
Filing date
11/13/2024
Registration date
04/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2026
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
10/21/2024
First use in commerce
10/21/2024
Drawing code
4
Owner type
03
Owner location
Fort Collins, CO, US
Examiner
LEIPZIG, MARC J
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Atlas Biologicals, Inc.
Representatives
Cheryl L. Anderson CR MILES P.C.
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Animal blood sera and blood serum componentsprimarily of fetalnewbornyoung bovine animal originfor scientific or medical research use
Publications
History of USPTO decisions and trademark events.
24 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/07/2026
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/11/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/10/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/15/2025
GNFR
FINAL REFUSAL E-MAILED
12/15/2025
CNFR
FINAL REFUSAL WRITTEN
12/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08/14/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
08/14/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2025
GNRT
NON-FINAL ACTION E-MAILED
05/14/2025
CNRT
NON-FINAL ACTION WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
05/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2025
NWAP
NEW APPLICATION ENTERED
11/13/2024
Continuous trademark protection
Get notified about every new filing that threatens FETAL RESERVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.